Trials / Active Not Recruiting
Active Not RecruitingNCT06747572
Polycystic Kidney Disease 1 (PKD1) Gene Variant Groups in Autosomal Dominant Polycystic Kidney Disease
A Study to Determine the Prevalence and Clinical Characteristics Associated With PKD1 Gene Variant Groups in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 401 (actual)
- Sponsor
- Vertex Pharmaceuticals Incorporated · Industry
- Sex
- All
- Age
- 12 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to estimate the prevalence, demographic, and clinical characteristics of PKD1/2 gene variant groups in the ADPKD population.
Conditions
Timeline
- Start date
- 2024-12-19
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
- First posted
- 2024-12-24
- Last updated
- 2026-02-11
Locations
45 sites across 9 countries: United States, Belgium, Canada, France, Germany, Netherlands, Puerto Rico, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT06747572. Inclusion in this directory is not an endorsement.